Anita Spieth Speaking at ACI’s 9th Annual Paragraph IV Disputes Master Symposium

Anita Spieth will be a panelist at the ACI’s 9th Annual Paragraph IV Disputes Master Symposium on Tuesday, October 24th. The panel, "Patents, Drug Pricing, and Price Controls: Understanding the Inflation Reduction Act (IRA) Will Impact The Value of Pharmaceutical IP" will take place at 8:15 a.m. and will focus on the following:

• Analyzing how the IRA’s provisions on drug pricing is impacting pharmaceutical patents.
• Appreciating the significance of Merck v. Becerra with respect to pro-competitive intent of Hatch-Waxman?
• Evaluating the potential impact of the IRA on pharmaceutical patent litigation
• Understanding the impact on coordination and discovery
• Exploring how the IRA can encourage settlement of infringement litigation
• Practical strategies for safeguarding IP value when your drug is selected for negotiation

The conference will take place at the Hyatt Regency McCormick Place in Chicago. More information about the event can be found here.